MPM BioVentures 2014 (B), L.P.

CIK 1609493 · last filed 2025-11-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$33.36M

Companies

3

Total Filings

24

Lifetime Open-Market Net

-$43.64M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HOWL 10%+ Owner 5,731,860 $0.38 $2.20M -$1.21M 1 2025-11-12
iTeos Therapeutics, Inc. (ITOS) Delisted 10%+ Owner 2,771,359 $10.15 $28.13M -$60.44M 2 2022-01-06
TRDA 10%+ Owner 4,425,784 $7.04 $31.16M $18.00M 1 2021-11-04

Recent Filings · Page 3 of 3

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-06-05 Other (J) −33,271,712 $0
2022-01-06 iTeos Therapeutics, Inc. (ITOS) Delisted Sell (S) −1,320,165 -$56.21M EDGAR
2021-11-04 TRDA Mixed +39,832,056 $18.00M EDGAR
2021-10-18 iTeos Therapeutics, Inc. (ITOS) Delisted Sell (S) −153,891 -$4.22M EDGAR
Showing 2124 of 24
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.